White Paper
Articles
News
Updates
2020 - December
Dapagliflozin Propane Diol
Brazil DMF
2020 - December
Abiraterone Acetate
Brazil DMF
2020 - December
Sugammadex Sodium
China DMF
2020 - December
Lurasidone HCl
China DMF
2020 - December
Raloxifene HCl
China DMF
2020 - December
Apremilast (Form-B)
China DMF
2020 - December
Atorvastatin Calcium [Form-1] [ATN]
Korea DMF
2020 - December
Rabeprazole Sodium (Amorphous)
CEP Submitted
2020 - December
Pregabalin
Japan DMF
2020 - December
Famotidine
Japan DMF
2020 - December
Lenalidomide
USDMF
2020 - December
Clopidogrel Bisulfate
USDMF
2020 - December
Roxadustat
USDMF
2020 - December
Elagolix
USDMF
2020 - December
Atorvastatin Calcium Trihydrate [Form-1] [ATN]
Brazil DMF
2020 - December
Montelukast Sodium USP
Brazil DMF
2020 - December
Pregabalin
Brazil DMF
2020 - December
Capecitabine
Brazil DMF
2020 - November
Sitagliptin Phosphate (Anhydrous)
China DMF
2020 - November
Dutasteride (Form-II)
Canada DMF
2020 - November
Rabeprazole Sodium Hydrate (form-Y) RBL process
CEP Submitted
2020 - November
Clopidogrel Bisulphate [Form-I] (CIP)
Brazil DMF
2020 - October
Divalproex Sodium
Brazil DMF
2020 - October
Rivaroxaban
Brazil DMF
2020 - October
Mirabegron Amorphous
Brazil DMF
2020 - September
Losartan K
Brazil DMF
2020 - September
Ondansetron HCl
China DMF
2020 - September
Canagliflozin Hemihydrate
China DMF
2020 - September
Raloxifene HCl
Korea DMF
2020 - September
Escitalopram Oxalate
Korea DMF
2020 - September
Ticagrelor
CEP Submitted
2020 - September
Fexofenadine HCl ( form X)
Japan DMF
2020 - September
Midostaurin
USDMF
2020 - August
Keterolac Tromethamine
Brazil DMF
2020 - August
Ondansetron Hydrochloride
Brazil DMF
2020 - August
Sitagliptin Phosphate Anhydrous
Brazil DMF
2020 - August
Naratriptan Hydrochloride
Brazil DMF
2020 - August
Valsartan [micronized]
Brazil DMF
2020 - August
Pregabalin
China DMF
2020 - August
Tizanidine
CEP Submitted
2020 - July
Montelukast Sodium Ph.Eur.
Brazil DMF
2020 - July
Gemcitabine Hydrochloride
Brazil DMF
2020 - July
Sertraline HCl (SET4L)
Brazil DMF
2020 - July
Rivaraoxaban
CEP Submitted
2020 - June
Ticagrelor
Brazil DMF
2020 - June
Levetiracetam
Brazil DMF
2020 - June
Clopidogrel Bisulphate Form-1
Brazil DMF
2020 - June
Sugammadex Sodium
Brazil DMF
2020 - June
Sitagliptin HCl (CIP)
Korea DMF
2020 - June
Icatibant Acetate
Europe ASMF filed
2020 - June
Azacitidine
Japan DMF
2020 - June
Liraglutide
USDMF
2020 - May
Valsartan
Canada DMF
2020 - May
Esclicabazepine Acetate
Europe ASMF filed
2020 - May
Abiraterone acetate
Europe ASMF filed
2020 - April
Valsartan [Compacted]
Brazil DMF
2020 - April
Dasatinib SPG Solvate
Brazil DMF
2020 - April
Atorvastatin Calcium Trihydrate (Form-1)
Canada DMF
2021 - December
Moxifloxacin hydrochloride
Brazil DMF
2021 - December
Mirabegron [Alpha]
Brazil DMF
2021 - December
Sitagliptin Phosphate MH
Brazil DMF
2021 - November
Eribulin Mesylate
USDMF
2021 - November
Sacubitril/Valsartan
China DMF
2021 - November
Gemcitabine Hydrochloride
China DMF
2021 - November
Azacitidine
China DMF
2021 - November
Rivaroxaban (Ph.Eur)
Brazil DMF
2021 - November
Lenalidomide [Form-A]
CEP Submitted
2021 - October
Quetiapine Fumarate (Ph.Eur)
Brazil DMF
2021 - October
Quetiapine Fumarate (USP)
Brazil DMF
2021 - October
Rabeprazole Sodium (Form-Y)
Brazil DMF
2021 - October
Pioglitazone Hydrochloride
Japan DMF
2021 - October
Atorvastatin Calcium (Amorphous)
Brazil DMF
2021 - September
Enalaprilat
USDMF
2021 - September
Atorvastatin Calcium [Form-P]
Brazil DMF
2021 - September
Dabigatran Etexilate Mesilate [Form-2]
Brazil DMF
2021 - September
Dutasteride [Form-II]
Brazil DMF
2021 - September
Cinacalcet HCl
China DMF
2021 - September
Mirabegron (Alpha)
China DMF
2021 - August
Ibandronate Sodium Monohydrate [Form-B]
Brazil DMF
2021 - July
Edaravone
CEP Submitted
2021 - July
Ranolazine
CEP Submitted
2021 - July
Enzalutamide
Brazil DMF
2021 - July
Metoprolol Succinate FW
Brazil DMF
2021 - June
Lenvatinib mesylate (Form C)
USDMF
2021 - June
Dapagliflozin PG Solvate [Micronized]
Korea DMF
2021 - June
Clopidogrel Bisulphate [Form-II]
Korea DMF
2021 - June
Olanzapine [Form-I]
Korea DMF
2021 - June
Levofloxacin (USP) Hemihydrate
Korea DMF
2021 - June
Azacitidine
Brazil DMF
2021 - June
Pregabalin
Brazil DMF
2021 - June
Diluted Everolimus
Brazil DMF
2021 - June
Atorvastatin Calcium Trihydrate [Form-I] USP
Brazil DMF
2021 - June
Midostaurin - Crystalline Form II
Brazil DMF
2021 - May
Dimethyl Fumarate
EDMF filed
2021 - May
Olanzapine
Korea DMF
2021 - May
Ropinirole
CEP Submitted
2021 - May
Rivastigmine HT P-1
CEP Submitted
2021 - May
Esomeprazole Magnesium Trihydrate
CEP Submitted
2021 - May
Eribulin Fragment A
USDMF
2021 - April
Pregabalin
USDMF
2021 - March
Lenalidomide (LEU1)
Brazil DMF
2021 - March
Losartan Potassium
Japan DMF
2021 - March
Clopidogrel Bi-sulfate (Form-II)
Japan DMF
2021 - March
Amlodipine Besilate
China DMF
2021 - March
Abiraterone Acetate
Japan DMF
2021 - March
Naproxen Sodium
Brazil DMF
2021 - March
Naproxen
Brazil DMF
2021 - March
Sitagliptin Phosphate Ph.Eur (monohydrate)
CEP Submitted
2021 - March
Apalutamide (Amorphous)
USDMF
2021 - March
Finasteride (Form-I)
China DMF
2021 - March
Ondansetron base
Brazil DMF
2021 - March
Rabeprazole Sodium [Amorphous]
Japan DMF
2021 - March
Dabigatran Etexilate Mesylate
Korea DMF
2021 - March
Bendamustine Hydrochloride
Brazil DMF
2021 - March
Sitagliptin Phosphate Monohydrate USP
Brazil DMF
2021 - March
Rabeprazole Sodium [Amorphous]
China DMF
2021 - March
Pregabalin
China DMF
2021 - March
Fingolimod Hydrochloride
China DMF
2021 - March
Dapagliflozin (Amorphous)
China DMF
2021 - March
Olaparib
USDMF
2021 - March
Diroximel Fumarate
USDMF
2021 - March
Sitagliptin Phosphate Monohydrate USP
USDMF
2021 - March
Lurasidone HCl
Brazil DMF
2021 - March
Atorvastatin Calcium Trihydrate [Form-I] ATN process
China DMF
2021 - March
Rivaroxaban
Korea DMF
2021 - March
Pazopanib Hydrochloride
USDMF
2021 - March
Finasteride (Form-I)
Brazil DMF
2021 - February
Permethrin-25:75
CEP Submitted
2021 - February
Pregabalin
Korea DMF
2021 - February
Ondansetron Hydrochloride
Korea DMF
2021 - February
Sitagliptin Phosphate USP (monohydrate)
USDMF
2021 - February
Hydroxychloroquine Sulfate
USDMF
2021 - February
Favipiravir
USDMF
2021 - February
Levetiracetam
Korea DMF
2021 - February
Clopidogrel Bisulphate Form-2
CEP Submitted
2021 - January
Bendamustine HCl
Canada DMF
2021 - January
Fexofenadine Form-1
CEP Submitted
2021 - January
Mirabegron
Europe ASMF filed
2022 - December
Capecitabine
Japan DMF
2022 - December
Dabigatran Etexilate Mesylate
China DMF
2022 - December
Naproxen
China DMF
2022 - November
Ketorolac Tromethamine
China DMF
2022 - October
Linagliptin
EUDMF
2022 - October
Linagliptin
Brazil DMF
2022 - October
Dimethyl Fumarate
EUDMF
2022 - October
Nilotinib Hydrochloride Monohydrate
Brazil DMF
2022 - October
Levocetirizine Dihydrochloride
Brazil DMF
2022 - October
Clopidogrel Bisulphate (Form - II)
China DMF
2022 - September
Sitagliptin Phosphate Monohydrate
Korea DMF
2022 - September
Sumatriptan Succinate USP
USDMF
2022 - September
Atorvastatin Calcium Trihydrate (Form-1)
Brazil DMF
2022 - September
Dimethyl Fumarate
Brazil DMF
2022 - September
Atorvastatin Calcium Trihydrate (Form-1)
Japan DMF
2022 - September
Clopidogrel Bisulfate [Form-II]
EUDMF
2022 - August
Metoprolol Succinate
CEP Submitted
2022 - August
Clopidogrel Bisulfate [Form-I] CIP
Brazil DMF
2022 - August
Moxifloxacin Hydrochloride USP
Brazil DMF
2022 - August
Fexofenadine Hydrochloride
Korea DMF
2022 - August
Clopidogrel Bisulfate [Form-II]
CEP Submitted
2022 - July
Nilotinib Hydrochloride
USDMF
2022 - July
Tofacitinib Citrate
USDMF
2022 - July
Eribulin Mesylate
Canada DMF
2022 - July
Palbociclib [Form-A]
Brazil DMF
2022 - June
Bempedoic Acid
Brazil DMF
2022 - June
Lurasidone Hydrochloride
EUDMF
2022 - June
Eribulin Mesylate
EUDMF
2022 - May
Ticagrelor
Russia DMF
2022 - May
Escitalopram Oxalate
CEP Submitted
2022 - May
Sugammadex Sodium
Taiwan DMF
2022 - May
Sitagliptin Phosphate Monohydrate
CEP Submitted
2022 - April
Losartan Potassium
Japan DMF
2022 - March
Siponimod Hemifumarate
USDMF
2022 - March
Bempedoic Acid
USDMF
2022 - March
Risperidone [Form-1]
Brazil DMF
2022 - March
Sacubitril + Valsartan Crystalline
Brazil DMF
2022 - March
Ramipril
Brazil DMF
2022 - March
Levofloxacin Hemihydrate
Brazil DMF
2022 - March
Voriconozole
Brazil DMF
2022 - March
Apremilast [Amorphous]
Brazil DMF
2022 - March
Apremilast [Form-B]
Brazil DMF
2022 - March
Siponimod Hemifumarate
Brazil DMF
2022 - March
Metoprolol Succinate
China DMF
2022 - March
Dapagliflozin PG Solvate
China DMF
2022 - March
Pemetrexed Disodium Heptahydrate
China DMF
2022 - March
Clopidogrel Bisulphate [Form-1]
Japan DMF
2022 - March
Rivaroxaban
Japan DMF
2022 - March
Lenalidomide [Form-A]
Japan DMF
2022 - March
Naratriptan Hydrochloride
Japan DMF
2022 - March
Fingolimod Hydrochloride
CEP DMF Filed
2022 - March
Sugammadex Sodium
Canada DMF
2022 - March
Apremilast Form B
Korea DMF
2022 - March
Rabeprazole Sodium [Amorphous]
Korea DMF
2022 - March
Sumatriptan Succinate
Korea DMF
2022 - March
Enzalutamide
Korea DMF
2022 - March
Sacubitril/Valsartan
Korea DMF
2022 - March
Pioglitazone Hydrochloride
Korea DMF
2022 - March
Montelukast Sodium
Korea DMF
2022 - March
Eribulin Mesylate
Australia DMF
2022 - March
Molnupiravir
WHO DMF Filed
2022 - March
Fexofenadine Hydrochloride (Form-I)
Brazil DMF
2022 - February
Omeprazole Magnesium
CEP Submitted
2022 - February
Dasatinib Monohydrate
Japan DMF
2022 - February
Dapagliflozin Amorphous
Brazil DMF
2022 - January
Losartan Potassium [Form-I]
Korea DMF
2022 - January
Losartan Potassium [Form-I]
Brazil DMF
2022 - January
Losartan Potassium [Form 1]
CEP Submitted
2022 - January
Capecitabine
Japan DMF
2023 - December
Cabozantinib (S)-Malate [Form N-2]
USDMF
2023 - December
Cabozantinib Intermediate (CZT3)*
USDMF
2023 - December
Ezetimibe (EZE)
USDMF
2023 - December
Lumateperone Tosylate
Brazil DMF
2023 - December
Roxadustat
Brazil DMF
2023 - December
Pantoprazole sodium sesquihydrate (Form-I) Ph. Eur
Brazil DMF
2023 - December
Rabeprazole sodium Ph. Eur
Brazil DMF
2023 - December
Carfilzomib
Brazil DMF
2023 - December
Lenalidomide Form-A
China DMF
2023 - December
Dabigatran Etexilate Mesylate
CEP Submitted
2023 - December
Mirabegron (Alpha Form)
CEP Submitted
2023 - December
Lenvatinib Form-C
Korea DMF
2023 - December
Capecitabine
Korea DMF
2023 - December
Dasatinib Monohydrate
Korea DMF
2023 - November
Lansoprazole
China DMF
2023 - November
Ferric Carboxy Maltose
Australia DMF
2023 - November
Olaparib
Brazil DMF
2023 - November
Dapagliflozin Amorphous
Russia DMF
2023 - November
Mirabegron
Egypt DMF
2023 - October
Cabazitaxel
Egypt DMF
2023 - October
Sugammadex Sodium
Singapore DMF
2023 - October
Liraglutide
Canada DMF
2023 - October
Varenicline Tartrate
Brazil DMF
2023 - October
Ferric Carboxymaltose
EUDMF
2023 - October
Pantoprazole Sodium
EUDMF
2023 - October
Nilotinib Hydrochloride Monohydrate
Korea DMF
2023 - October
Dapagliflozin (Amorphous)
Israel DMF
2023 - October
Roxadustat Form-A
China DMF
2023 - October
Nilotinib Hydrochloride Monohydrate
Australia DMF
2023 - October
Tafamidis Meglumine
Brazil DMF
2023 - September
Fosaprepitant Dimeglumine
Brazil DMF
2023 - September
Pregabalin
Canada DMF
2023 - September
Apixaban
Australia DMF
2023 - September
Sitagliptin hydrochloride Monohydrate
Saudi Arabia
2023 - September
Azacitidine
Egypt DMF
2023 - September
Linagliptin
Saudi Arabia
2023 - September
Dapagliflozin Amorphous
EUDMF
2023 - September
Omeprazole Magnesium
USDMF
2023 - September
Fexofenadine HCl Form I
Brazil DMF
2023 - August
Varenicline Tartrate
USDMF
2023 - August
Olaparib [Form-A]
China DMF
2023 - July
Linagliptin
Australia DMF
2023 - July
Liraglutide
EUDMF
2023 - July
Gatifloxacin Anhydrous
Brazil DMF
2023 - June
Nilotinib Hydrochloride Monohydrate
CEP Submitted
2023 - June
Tofacitinib Citrate
Brazil DMF
2023 - June
Rabeprazole Sodium
Russia DMF
2023 - June
Linagliptin
Canada DMF
2023 - June
Esomeprazole Magnesium Trihydrate
China DMF
2023 - May
Sugammadex Sodium
Japan DMF
2023 - May
Midostaurin
Australia DMF
2023 - May
Ramipril
Russia DMF
2023 - May
Moxifloxacin Hydrochloride
Singapore DMF
2023 - May
Pantoprazole Sodium Sesquihydrate
CEP Submitted
2023 - April
Ciprofloxacin Hydrochloride
China DMF
2023 - April
Telmisartan
GCC DMF
2023 - April
Bortezomib
Egypt DMF
2023 - March
Fosaprepitant Dimeglumine
USDMF
2023 - March
TBA-7A / Sitagliptin N-Boc Acid
USDMF
2023 - March
Salcaprozate Sodium
USDMF
2023 - March
Cabozantinib Hydrochloride
USDMF
2023 - March
Lumateperone Tosylate
USDMF
2023 - March
Clopidogrel Bisulphate [Form-II] USP DIFA
Brazil DMF
2023 - March
Cetirizine Dihydrochloride USP
Brazil DMF
2023 - March
Fluoxetine Hydrochloride USP
Brazil DMF
2023 - March
Lenvatinib Mesylate (Form C)
Brazil DMF
2023 - March
Pioglitazone Hydrochloride USP
Brazil DMF
2023 - March
Pioglitazone Hydrochloride Ph. Eur
Brazil DMF
2023 - March
Pantoprazole Sodium Sesquihydrate
Brazil DMF
2023 - March
Levofloxacin Hemihydrate Ph.Eur
Brazil DMF
2023 - March
Pemetrexed Disodium (Heptahydrate)
CEP Submitted
2023 - March
Nilotinib Hydrochloride Monohydrate
Canada DMF
2023 - March
Dimethyl Fumarate
China DMF
2023 - March
Montelukast Sodium
China DMF
2023 - March
Voriconazole CIP
China DMF
2023 - March
Nilotinib Hydrochloride
China DMF
2023 - March
Rivastigmine
China DMF
2023 - March
Valsartan
Japan DMF
2023 - March
Abiraterone Acetate
Korea DMF
2023 - March
Naratriptan Hydrochloride
Korea DMF
2023 - March
Enzalutamide
Taiwan DMF
2023 - March
Enzalutamide
Singapore DMF
2023 - February
Esomeprazole Magnesium Trihydrate
CEP Submitted
2023 - February
Atorvastatin Calcium Trihydrate (Form-1) USP
China DMF
2023 - February
Tafamidis Meglumine
USDMF
2023 - February
Pemetrexed Disodium (Heptahydrate)
Korea DMF
2023 - February
Sumatriptan succinate
Brazil DMF
2023 - January
Sumatriptan succinate
CEP Submitted
2023 - January
Abiraterone Acetate
Brazil DMF
2023 - January
Pregabalin
Brazil DMF
2023 - January
Apalutamide Form-B
Brazil DMF
2024 - December
Quetiapine Fumarate
Japan DMF
2024 - December
Cinacalcet Hydrochloride
China DMF
2024 - December
Abemaciclib
Brazil DMF
2024 - December
Dabigatran Etexilate Mesylate (P2)
Brazil DMF
2024 - December
Sitagliptin Phosphate Monohydrate (Product code:SPT-4)
CEP Submitted
2024 - December
Abemaciclib
USDMF
2024 - December
Voclosporin
USDMF
2024 - December
Mavacamten
USDMF
2024 - November
Ketorolac Tromethamine (Parenteral)
Brazil DMF
2024 - November
Moxifloxacin Hydrochloride
Egypt DMF
2024 - November
Ferric Carboxy Maltose
Malaysia DMF
2024 - November
Atorvastatin Calcium Trihydrate (Form-1) (ATO-3 route)
Oman DMF
2024 - November
Siponimod Hemifumarate
Australia DMF
2024 - October
Benztropine Mesylate
Saudi Arabia
2024 - October
Dimethyl Fumarate
Saudi Arabia
2024 - October
Memantine Hydrochloride
Russia DMF
2024 - October
Sitagliptin Phosphate Monohydrate
USDMF
2024 - October
Cabozantinib (S)-Malate [Form N-2]
Brazil DMF
2024 - October
Sacubitril Sodium
Brazil DMF
2024 - October
Ferric Carboxy Maltose
China DMF
2024 - October
Ezetimibe
Brazil DMF
2024 - October
Sitagliptin Phosphate Monohydrate
Brazil DMF
2024 - October
Dasatinib Monohydrate
Brazil DMF
2024 - October
Dabigatran Etexilate Mesylate
USDMF
2024 - October
Empagliflozin [Product code: EGF8]
Canada DMF
2024 - October
Naproxen Sodium Ph. Eur
Brazil DMF
2024 - October
Linagliptin Form (A+B)
EUDMF
2024 - August
Sacubitril/Valsartan
Australia DMF
2024 - August
Dabigatran Etexilate Mesylate
CEP Submitted
2024 - August
Sacubitril Sodium
USDMF
2024 - July
Dasatinib Monohydrate
Australia DMF
2024 - July
Lenvatinib Mesylate Form-C
Australia DMF
2024 - July
Empagliflozin Crystalline [Micronized]
Australia DMF
2024 - June
Lanreotide
US filing
2024 - June
Mirabegron Ph. Eur
Brazil DMF
2024 - June
Dasatinib Monohydrate
Canada DMF
2024 - June
Nilotinib Hydrochloride Monohydrate
Taiwan DMF
2024 - June
Rivastigmine Hydrogen Tartrate
Taiwan DMF
2024 - June
Midostaurin Amorphous
India
2024 - June
Bempedoic Acid
India
2024 - June
Pantoprazole Sodium Sesiquihydrate
Saudi Arabia
2024 - May
Ketorolac Tromethamine
Saudi Arabia
2024 - May
Enzalutamide
Canada DMF
2024 - April
Cabazitaxel
Taiwan DMF
2024 - March
Relugolix
USDMF
2024 - March
Ruxolitinib Phosphate
USDMF
2024 - March
Lenvatinib Mesylate (Form-C)
Canada DMF
2024 - March
Levocetirizine Dihydrochloride
CEP Submitted
2024 - March
Irbesartan
CEP Submitted
2024 - March
Relugolix Sodium
Brazil DMF
2024 - March
Ruxolitinib Phosphate
Brazil DMF
2024 - March
Carfilzomib
China DMF
2024 - March
Decitabine
Korea DMF
2024 - February
Edaravone
Brazil DMF
2024 - February
Ripretinib
USDMF
2024 - February
Ripretinib
Brazil DMF
2024 - February
Vonoprazan Fumarate
USDMF
2024 - February
Vonoprazan Fumarate
Brazil DMF
2024 - February
Ondansetron
Canada DMF
2024 - February
Dabigatran Etexilate Mesylate
Russia DMF
2024 - February
Permethrin BPC cis trans 25 75
Korea DMF
2024 - February
Lomustine
China DMF
2024 - February
Pantoprazole Sodium Sesiquihydrate
China DMF
2024 - February
Donepezil Hydrochloride Monohydrate (Form-1)
CEP Submitted
2024 - January
Lenalidomide Form-A
Japan DMF
2024 - January
Linagliptin Form A+B
Brazil DMF
2025 - December
Atorvastatin Calcium Trihydrate [Form-I]
USA
2025 - December
Nilotinib Premix (HPMC AS)
USA
2025 - December
Abemaciclib
Canada DMF
2025 - December
Sumatriptan Succinate
Japan DMF
2025 - December
Tafamidis Meglumine
Canada DMF
2025 - December
Rivaroxaban (Process-II)
USA
2025 - December
Naratriptan Hydrochloride
Russia DMF
2025 - December
Lomustine
Russia DMF
2025 - December
Fondaparinux Sodium
Saudi Arabia
2025 - December
Fondaparinux Sodium
EU
2025 - November
Linagliptin
UK
2025 - November
Pemetrexed Disodium
Saudi Arabia
2025 - November
Empagliflozin
Saudi Arabia
2025 - November
Carfilzomib
EU
2025 - November
Empagliflozin
Australia DMF
2025 - November
Empagliflozin
Singapore DMF
2025 - November
Dapagliflozin Amorphous
Indonesia
2025 - November
Dapagliflozin Propanediol
Singapore DMF
2025 - October
Tizanidine Hydrochloride
CEP DMF Filed
2025 - October
Naproxen Sodium
Malaysia DMF
2025 - October
Montelukast Sodium
Benin
2025 - October
Empagliflozin
Malaysia DMF
2025 - October
Dasatinib Monohydrate
Saudi Arabia
2025 - October
Carfilzomib
Japan DMF
2025 - October
Tucatinib Hemiethanolate
India
2025 - October
Lurasidone hydrochloride
Taiwan DMF
2025 - September
Deucravacitinib
Brazil DMF
2025 - September
Mirabegron (alpha)
Saudi Arabia
2025 - September
Palbociclib
Australia DMF
2025 - September
Valsartan, Essential Amorphous Form
Europe (CEP)
2025 - September
Erubilin
Saudi Arabia
2025 - September
Azacitidine
Saudi Arabia
2025 - September
Palonosetron Hydrochloride
Brazil DMF
2025 - September
Dapagliflozin Propanediol
Europe (CEP)
2025 - September
Gemcitabine Hydrochloride
Saudi Arabia
2025 - August
Apixaban
Sweden
2025 - August
Apixaban
Singapore DMF
2025 - August
Cetirizine Dihydrochloride
Egypt DMF
2025 - August
Ruxolitinib Hemifumarate
Australia DMF
2025 - August
Edoxaban Tosylate Monohydrate
Brazil DMF
2025 - August
Lenalidomide Povidone Premix
Egypt DMF
2025 - August
Tucatinib Copovidone ASD
USDMF
2025 - August
Gemcitabine Hydrochloride
Saudi Arabia
2025 - July
Permethrin
Saudi Arabia
2025 - July
Liraglutide
Saudi Arabia
2025 - July
Relugolix
India
2025 - July
Voriconazole
Russia DMF
2025 - July
Edoxaban Tosylate
USDMF
2025 - June
Cabazitaxe
Kenya
2025 - June
Docetaxel Anhydrous
Kenya
2025 - June
Palonosetron Hydrochloride USP
Ethiopia
2025 - June
Cabazitaxel
Kenya
2025 - June
Tucatinib Hemiethanolate
Brazil DMF
2025 - May
Ruxolitinib Hemifumarate
Canada DMF
2025 - May
Dapagliflozin Amorphous
Switzerland
2025 - May
Nilotinib Hydrochloride Monohydrate
Indonesia
2025 - April
Bempedoic acid
Russia DMF
2025 - March
Montelukast Sodium
Japan DMF
2025 - March
Ruxolitinib Hemifumarate
Canada DMF
2025 - March
Apixaban
Taiwan DMF
2025 - March
Palbociclib
Canada DMF
2025 - March
Deucravacitinib
USDMF
2025 - March
Finerenone
USDMF
2025 - March
Niraparib Tosylate Monohydrate
USDMF
2025 - March
Tucatinib
USDMF
2025 - March
Voclosporin
Brazil DMF
2025 - March
Lanreotide
Brazil DMF
2025 - March
Pomalidomide
2025 - March
Vonoprazan Fumarate
Korea DMF
2025 - March
Palbociclib
Korea DMF
2025 - March
Ezetimibe (Unmicronized)
Korea DMF
2025 - March
Mavacamten Form-A
Brazil DMF
2025 - March
Fexofenadine HCl (Form-1) -FXA4 process
CEP Submitted
2025 - March
Amlodipine Besylate (TY45)
CEP Submitted
2025 - March
Tucatinib Hemiethanolate
USDMF
2025 - March
Tizanidine Hydrochloride USP (TZN-Process)
USDMF
2025 - March
Enzalutamide Premix (20% w/w)
USDMF
2025 - March
Pazopanib HCl
EUDMF
2025 - March
Atorvastatin Calcium Trihydrate form-1 [ATO-3 process]
CEP Submitted
2025 - March
Ezetimibe (Micronized)
Korea DMF
2025 - February
Montelukast Sodium
Japan DMF
2025 - February
Pioglitazone Hydrochloride
Canada DMF
2025 - February
Cabozantinib S- Maleate (N2 Form)
Korea DMF
2025 - February
Ruxolitinib Hemifumarate
Israel DMF
2025 - February
Palbociclib
Singapore DMF
2025 - February
Ferric Carboxy Maltose
Saudi Arabia
2025 - January
Fexofenadine Form I
Brazil DMF
2025 - January
Sacubitril/ Valsartan
Canada DMF
2025 - January
Dasatinib Monohydrate
Taiwan DMF
2025 - January
Pazopanib
Taiwan DMF